Terns Pharmaceuticals (TERN) Other Gross PP&E Adjustments (2020 - 2023)
Historic Other Gross PP&E Adjustments for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to -$2.6 million.
- Terns Pharmaceuticals' Other Gross PP&E Adjustments fell 2869.65% to -$2.6 million in Q3 2023 from the same period last year, while for Dec 2023 it was -$2.6 million, marking a year-over-year decrease of 718.1%. This contributed to the annual value of -$2.4 million for FY2022, which is 47550.08% down from last year.
- Latest data reveals that Terns Pharmaceuticals reported Other Gross PP&E Adjustments of -$2.6 million as of Q3 2023, which was down 2869.65% from -$3.0 million recorded in Q2 2023.
- Terns Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $649000.0 during Q4 2021, with a 5-year trough of -$3.0 million in Q2 2023.
- In the last 4 years, Terns Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$2.2 million in 2022 and averaged -$1.6 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 30218.07% in 2021, then tumbled by 47550.08% in 2022.
- Quarter analysis of 4 years shows Terns Pharmaceuticals' Other Gross PP&E Adjustments stood at -$321000.0 in 2020, then soared by 302.18% to $649000.0 in 2021, then plummeted by 475.5% to -$2.4 million in 2022, then decreased by 8.58% to -$2.6 million in 2023.
- Its Other Gross PP&E Adjustments stands at -$2.6 million for Q3 2023, versus -$3.0 million for Q2 2023 and -$2.5 million for Q1 2023.